Active implantable device vulnerability to interference from theft detection systems probed by FDA.
This article was originally published in The Gray Sheet
ACTIVE IMPLANTS' VULNERABILITY TO RETAIL STORE SECURITY SYSTEM INTERFERENCE is being investigated by FDA. The agency is asking manufacturers of electronic article surveillance (EAS) systems to submit data to help it determine if the systems, which are commonly found in retail stores, pose a risk of electromagnetic interference with pacemakers, implantable cardioverter defibrillators, and other active implantable medical devices.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.